Quantum-Si incorporated (NASDAQ:QSI – Free Report) – Equities research analysts at HC Wainwright raised their Q1 2025 earnings per share estimates for Quantum-Si in a report issued on Tuesday, March 4th. HC Wainwright analyst S. Ramakanth now expects that the company will post earnings per share of ($0.17) for the quarter, up from their previous estimate of ($0.18). HC Wainwright currently has a “Buy” rating and a $5.50 target price on the stock. The consensus estimate for Quantum-Si’s current full-year earnings is ($0.65) per share. HC Wainwright also issued estimates for Quantum-Si’s Q2 2025 earnings at ($0.16) EPS, Q3 2025 earnings at ($0.16) EPS, Q4 2025 earnings at ($0.16) EPS, FY2025 earnings at ($0.66) EPS, FY2026 earnings at ($0.60) EPS, FY2027 earnings at ($0.43) EPS and FY2028 earnings at ($0.21) EPS.
Several other brokerages have also commented on QSI. Alliance Global Partners began coverage on Quantum-Si in a research note on Friday, February 7th. They set a “buy” rating and a $3.75 price target on the stock. Canaccord Genuity Group cut their target price on Quantum-Si from $1.50 to $1.00 and set a “hold” rating on the stock in a research note on Wednesday, November 13th.
Quantum-Si Trading Down 8.2 %
NASDAQ:QSI opened at $1.29 on Thursday. The company has a market cap of $183.39 million, a price-to-earnings ratio of -2.01 and a beta of 2.75. Quantum-Si has a twelve month low of $0.61 and a twelve month high of $5.77. The stock has a fifty day simple moving average of $2.22 and a 200-day simple moving average of $1.45.
Insider Buying and Selling at Quantum-Si
In other Quantum-Si news, Director Jonathan M. Rothberg sold 3,506,267 shares of Quantum-Si stock in a transaction dated Friday, December 27th. The stock was sold at an average price of $3.34, for a total value of $11,710,931.78. Following the transaction, the director now owns 1,250,000 shares in the company, valued at $4,175,000. The trade was a 73.72 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 30.04% of the stock is owned by insiders.
Institutional Investors Weigh In On Quantum-Si
Institutional investors have recently added to or reduced their stakes in the business. Wolverine Asset Management LLC acquired a new stake in Quantum-Si in the fourth quarter worth about $26,000. Abel Hall LLC acquired a new stake in Quantum-Si in the fourth quarter worth about $28,000. Dudley Capital Management LLC acquired a new stake in Quantum-Si in the fourth quarter worth about $30,000. Jump Financial LLC acquired a new stake in Quantum-Si in the fourth quarter worth about $33,000. Finally, Cetera Investment Advisers acquired a new stake in Quantum-Si in the fourth quarter worth about $36,000. Institutional investors and hedge funds own 39.90% of the company’s stock.
Quantum-Si Company Profile
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.
Featured Stories
- Five stocks we like better than Quantum-Si
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Investing in Small-Cap AI: Powering the Next Tech Revolution
- Best Stocks Under $5.00
- Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?
- What is Forex and How Does it Work?
- Super Micro Computer Is Now NASDAQ Compliant—But Is It a Buy?
Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.